Skip to content
CUVLClinuvel Pharmaceuticals Ltd

CUVL holders

Who holds Clinuvel Pharmaceuticals Ltd, from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Managers
1
Shares held
20.5K
Value held
$121.9K
Opened
—
Closed
—

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Shade Tree Advisors LLC20.5K—$121.9K0.1%Oct 22, 2026